{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:22:06Z","timestamp":1760296926769},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,3,1]]},"DOI":"10.1038\/sj.leu.2402842","type":"journal-article","created":{"date-parts":[[2003,3,28]],"date-time":"2003-03-28T15:24:54Z","timestamp":1048865094000},"page":"634-635","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones"],"prefix":"10.1038","volume":"17","author":[{"given":"Y L","family":"Chee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T L","family":"Holyoake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D J","family":"Culligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,3,19]]},"reference":[{"key":"BF2402842_CR1","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/sj.leu.2402634","volume":"16","author":"MK Andersen","year":"2002","unstructured":"Andersen MK, Pedersen-Bjergaard J, Kjeldsen L, Dufva IH, Brondum-Nielsen K . Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterised by trisomy 8. Leukemia 2002; 16: 1390\u20131393.","journal-title":"Leukemia"},{"key":"BF2402842_CR2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1182\/blood.V91.6.1833","volume":"91","author":"G Socie","year":"1998","unstructured":"Socie G, Deeg JC . Malignancies after haematopoietic stem cell transplantation. Many questions, some answers. Blood 1998; 91: 1833\u20131844.","journal-title":"Blood"},{"key":"BF2402842_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1182\/blood.V100.2.435","volume":"100","author":"RM Braziel","year":"2002","unstructured":"Braziel RM, Launder TM, Druker B, Olson SB, Magenis RE, Mauro MJ et al. Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience. Blood 2002; 100: 435\u2013441.","journal-title":"Blood"},{"key":"BF2402842_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.leu.2402791","volume":"17","author":"P Meeus","year":"2003","unstructured":"Meeus P, Demuynck H, Martiat PH, Michaux L, Wouters E, Hagemeijer A . Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib. Leukaemia 2003; 17: 465\u2013467.","journal-title":"Leukaemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402842.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402842","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402842.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:26:12Z","timestamp":1648761972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3,1]]}},"alternative-id":["BF2402842"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402842","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,1]]},"assertion":[{"value":"10 October 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}